GlassScriptPhysician profile
Rita Greene
NPI 1235517244
$572.49
in general payments reported to CMS, 2019-2025
17 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.65 · 2022: $33.08 · 2023: $259 · 2024: $139 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $81.11 | 2023 | Breztri, Farxiga |
| Sumitomo Pharma America, INC. | $76.93 | 2024-2025 | Gemtesa |
| Lilly USA, LLC | $65.57 | 2023-2024 | Mounjaro, Jardiance |
| Amgen INC. | $39.31 | 2023 | Repatha, Otezla |
| Insulet Corporation | $38.73 | 2023 | Omnipod |
| Procept Biorobotics Corporation | $38.20 | 2025 | |
| Novo Nordisk INC | $36.01 | 2023-2024 | Ozempic, Rybelsus |
| Tolmar, INC. | $28.13 | 2025 | Eligard, Jatenzo |
| Axonics, INC. | $24.12 | 2024 | Axonics |
| Corcept Therapeutics | $21.41 | 2023 | Korlym |
| Coloplast Corp | $18.91 | 2024 | |
| Glaxosmithkline, LLC. | $18.75 | 2023 | Shingrix, Trelegy Ellipta |
| Hologic Sales and Service, LLC | $18.51 | 2022 | |
| Antares Pharma, INC. | $17.65 | 2021 | |
| Medtronic, INC. | $17.31 | 2025 | Interstim |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $17.27 | 2023 | Auvelity |
| Abbott Laboratories | $14.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.